Skip to main content
. 2022 Aug 30;23:224. doi: 10.1186/s12931-022-02149-9

Table 3.

Changes in FEV1/FVC and patterns of ventilatory defect from baseline to 2 weeks, 6 months, and 1 year after surgery

Before surgery 2 weeks after surgery 6 months after surgery 1 year after surgery
Overall
 FEV1/FVC (%)
  Adjusted mean (SE) 73.9 (0.3) 75.1 (0.3) 74.2 (0.3) 73.6 (0.4)
  Change from baseline (95% CI)a Reference 1.3 (0.8, 1.7) 0.4 (− 0.1, 0.9) − 0.3 (− 0.8, 0.3)
 Obstructive pattern
  Adjusted proportion (SE) 20.2 (1.5) 20.4 (1.6) 22.1 (1.6) 25.8 (1.8)
  Odds ratio (95% CI)a Reference 1.0 (0.8, 1.1) 1.0 (0.8, 1.2) 1.2 (1.0, 1.3)
 Restrictive pattern
  Adjusted proportion (SE) 7.4 (1.0) 57.8 (1.9) 33.1 (1.9) 23.5 (1.8)
  Odds ratio (95% CI)a Reference 7.8 (6.0, 10.3) 4.5 (3.4, 5.8) 3.2 (2.4, 4.1)
Type of surgery
 FEV1/FVC (%)
 Adjusted mean (SE)
  Wedge resection/segmentectomy 73.6 (0.7) 74.7 (0.7) 73.4 (0.8) 73.1 (0.8)
  Lobectomy 74.0 (0.3) 75.3 (0.4) 74.3 (0.4) 73.6 (0.4)
  Pneumonectomy/bilobectomy 73.0 (1.7) 74.6 (1.7) 77.4 (1.8) 75.5 (2.0)
  P-values 0.79 0.73 0.12 0.55
 Obstructive pattern
 Adjusted proportion (SE)
  Wedge resection/segmentectomy 25.1 (3.8) 22.4 (3.7) 24.4 (3.9) 27.2 (4)
  Lobectomy 21.7 (1.7) 21.7 (1.7) 22.3 (1.8) 25.8 (1.9)
  Bilobectomy/pneumonectomy 23.0 (7.3) 17.3 (6.7) 13.5 (6.1) 22.0 (7.7)
  P-values 0.69 0.83 0.44 0.85
 Restrictive pattern
 Adjusted proportion (SE)
  Wedge resection/segmentectomy 4.9 (2) 44.6 (4.5) 15.5 (3.4) 9.1 (2.8)
  Lobectomy 6.8 (1.1) 60.0 (2.2) 35.8 (2.3) 25.7 (2.1)
  Bilobectomy/pneumonectomy 26.7 (9) 72.3 (10.4) 67.0 (10.9) 48.2 (11.7)
  P-values  < 0.01  < 0.01  < 0.01  < 0.01

An obstructive pattern was defined as FEV1/FVC < 70%; a restrictive pattern was defined as both FEV1/FVC ≥ 70% and FVC < 80% predicted

CI confidence interval, FEV1 forced expiratory volume in 1 s; FVC forced expiratory vital capacity, SE standard error

aAdjusted for age, sex, stage, obesity, smoking status, cell type, type of surgery, video-assisted thoracic surgery, postoperative pulmonary complications, and adjuvant treatment